ViAn Therapeutics
Protecting sight with a simple eye drop.
San Francisco, United States · Founded 2023 · $275K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- viantx.com
- Total Funding
- $275K
- Last Round
- $275K SeedOct 2023
- Rounds
- 1
About
VIAN Therapeutics is a virtual pharma startup developing a topical antiangiogenic eye drop (VIAN-001) to treat retinal vascular diseases including AMD and diabetic macular edema. Their lead compound inhibits VEGF and Ang-2 to prevent pathological angiogenesis and vascular permeability. The company is backed by IndieBio and founded by Dr. Juan Pablo Robles.
Summary
ViAn Therapeutics is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $275K in total across 1 round, most recently a $275K Seed round in Oct 2023. Investors include IndieBio, Sand Hill Angels and Ulu Ventures.
Funding History
Oct 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vian-therapeutics"><img src="https://indexed.vc/api/badge/company/vian-therapeutics" alt="ViAn Therapeutics on Indexed.vc" width="260" height="76" /></a>